☆ 4.5 Article

Patient preferences for attributes of injected or infused preventive migraine medications: Findings from a discrete choice experiment

HEADACHE (2023)

Related references

Note: Only part of the references are listed.

Article Clinical Neurology

Patient preference for early onset of efficacy of preventive migraine treatments

Jessica Ailani et al.

Summary: This study aimed to determine the extent to which adults with migraine value the early onset of efficacy for preventive migraine treatments. Results showed that most participants considered the reduction in the likelihood of migraine on the first day postdosing to be at least as important as a clinically relevant reduction in migraine days during the first month postdosing.

HEADACHE (2022)

Add to Collection

Article Clinical Neurology

Patients and general practitioners assessment of the main outcomes employed in the acute and preventive treatment of migraine: a cross sectional study

Javier Trigo-Lopez et al.

Summary: The study compared patients and general practitioners' opinions about different variables related to migraine treatment. Results showed that effectiveness was the most important variable, while cost was considered the least important. Both patients and doctors desired efficacy percentage above 75% for both symptomatic and preventive treatment, with desired action times below 30 minutes for acute treatment and 2 weeks for preventive treatment.

BMC NEUROLOGY (2021)

Add to Collection

Article Clinical Neurology

The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice

Jessica Ailani et al.

Summary: This update aims to incorporate recent research findings, expert consensus, and patient perspectives into updated guidance on the use of new acute and preventive treatments for migraine in adults. It provides practical recommendations based on expanded evidence base and emerging expert consensus, in the absence of a formal guideline.

HEADACHE (2021)

Add to Collection

Review Clinical Neurology

Patient Preferences and Values in Decision Making for Migraines: A Systematic Literature Review

Xianpeng Xu et al.

Summary: This study comprehensively summarized the evidence on the preferences and values of migraine patients, finding that efficacy is the primary consideration in treatment. The most important aspects of patient preferences and values include a reduced frequency of attacks with preventive treatment and prompt pain relief with acute symptomatic treatment.

PAIN RESEARCH & MANAGEMENT (2021)

Add to Collection

Article Clinical Neurology

Rapid Onset of Effect of Galcanezumab for the Prevention of Episodic Migraine: Analysis of the EVOLVE Studies

Holland C. Detke et al.

HEADACHE (2020)

Add to Collection

Article Clinical Neurology

Eptinezumab Demonstrated Efficacy in Sustained Prevention of Episodic and Chronic Migraine Beginning on Day 1 After Dosing

David W. Dodick et al.

HEADACHE (2020)

Add to Collection

Article Biochemical Research Methods

Sensitivity and specificity of information criteria

John J. Dziak et al.

BRIEFINGS IN BIOINFORMATICS (2020)

Add to Collection

Article Clinical Neurology

Patient Preferences for Preventive Migraine Treatments: A Discrete-Choice Experiment

Carol Mansfield et al.

HEADACHE (2019)

Add to Collection

Article Clinical Neurology

Early onset of effect of onabotulinumtoxinA for chronic migraine treatment: Analysis of PREEMPT data

David W. Dodick et al.

CEPHALALGIA (2019)

Add to Collection

Article Clinical Neurology

Early Onset of Efficacy With Fremanezumab for the Preventive Treatment of Chronic Migraine

Paul K. Winner et al.

HEADACHE (2019)

Add to Collection

Article Clinical Neurology

Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition

Jes Olesen

CEPHALALGIA (2018)

Add to Collection

Article Clinical Neurology

Early onset of efficacy with erenumab in patients with episodic and chronic migraine

Todd Schwedt et al.

JOURNAL OF HEADACHE AND PAIN (2018)

Add to Collection

Article Clinical Neurology

Patients' preferences for headache acute and preventive treatment

Dimos D. Mitsikostas et al.

JOURNAL OF HEADACHE AND PAIN (2017)

Add to Collection

Article Economics

Statistical Methods for the Analysis of Discrete Choice Experiments: A Report of the ISPOR Conjoint Analysis Good Research Practices Task Force

A. Brett Hauber et al.

VALUE IN HEALTH (2016)

Add to Collection

Article Economics

Constructing Experimental Designs for Discrete-Choice Experiments: Report of the ISPOR Conjoint Analysis Experimental Design Good Research Practices Task Force

F. Reed Johnson et al.

VALUE IN HEALTH (2013)

Add to Collection

Article Clinical Neurology

Patients' preference for migraine preventive therapy

Mario Fernando Prieto Peres et al.

HEADACHE (2007)

Add to Collection

Article Clinical Neurology

Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability

WF Stewart et al.

NEUROLOGY (2001)

Add to Collection

© Peeref 2019-2024. All rights reserved.